157 related articles for article (PubMed ID: 37670966)
1. Cyclin dependent kinase 14 as a paclitaxel-resistant marker regulated by the TGF-β signaling pathway in human ovarian cancer.
Guan W; Yuan J; Li X; Gao X; Wang F; Liu H; Shi J; Xu G
J Cancer; 2023; 14(13):2538-2551. PubMed ID: 37670966
[TBL] [Abstract][Full Text] [Related]
2. The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance
Li X; Gao X; Yuan J; Wang F; Xu X; Wang C; Liu H; Guan W; Zhang J; Xu G
Front Endocrinol (Lausanne); 2022; 13():950345. PubMed ID: 36120434
[TBL] [Abstract][Full Text] [Related]
3. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL
J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA UCA1 promotes the progression of paclitaxel resistance in ovarian cancer by regulating the miR-654-5p/SIK2 axis.
Li ZY; Wang XL; Dang Y; Zhu XZ; Zhang YH; Cai BX; Zheng L
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):591-603. PubMed ID: 32016960
[TBL] [Abstract][Full Text] [Related]
5. Circ_0025033 deficiency suppresses paclitaxel resistance and malignant development of paclitaxel-resistant ovarian cancer cells by modulating the miR-532-3p/FOXM1 network.
Huang H; Yan L; Zhong J; Hong L; Zhang N; Luo X
Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):275-286. PubMed ID: 35196944
[TBL] [Abstract][Full Text] [Related]
6. RBM15‑mediating MDR1 mRNA m
Yuan J; Guan W; Li X; Wang F; Liu H; Xu G
Int J Oncol; 2023 Oct; 63(4):. PubMed ID: 37594126
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis.
Zhu L; Wang A; Gao M; Duan X; Li Z
Cancer Cell Int; 2020; 20():145. PubMed ID: 32377170
[TBL] [Abstract][Full Text] [Related]
8. Circ_0000231 promotes paclitaxel resistance in ovarian cancer by regulating miR-140/RAP1B.
Liu J; Wang H; Xiao S; Zhang S; Qi Y; Wang M
Am J Cancer Res; 2023; 13(3):872-885. PubMed ID: 37034216
[TBL] [Abstract][Full Text] [Related]
9. Highly expressed STAT1 contributes to the suppression of stemness properties in human paclitaxel-resistant ovarian cancer cells.
Wang F; Zhang L; Liu J; Zhang J; Xu G
Aging (Albany NY); 2020 Jun; 12(11):11042-11060. PubMed ID: 32516753
[TBL] [Abstract][Full Text] [Related]
10. CircATL2 enhances paclitaxel resistance of ovarian cancer via impacting miR-506-3p/NFIB axis.
Ying H; Zhao R; Yu Q; Zhang K; Deng Q
Drug Dev Res; 2022 Apr; 83(2):512-524. PubMed ID: 34541682
[TBL] [Abstract][Full Text] [Related]
11. Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells.
Li X; He Y; Wei L; Zhang J; Li X; Cui W; Zhang S
J Pharm Pharmacol; 2021 Mar; 73(4):545-552. PubMed ID: 33793827
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of circNRIP1 Suppresses the Paclitaxel Resistance of Ovarian Cancer via Regulating the miR-211-5p/HOXC8 Axis.
Li M; Cai J; Han X; Ren Y
Cancer Manag Res; 2020; 12():9159-9171. PubMed ID: 33061608
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-Dependent Kinase 14 Promotes Cell Proliferation, Migration and Invasion in Ovarian Cancer by Inhibiting Wnt Signaling Pathway.
Ou-Yang J; Huang LH; Sun XX
Gynecol Obstet Invest; 2017; 82(3):230-239. PubMed ID: 27505004
[TBL] [Abstract][Full Text] [Related]
14. Tetrandrine Reverses Paclitaxel Resistance in Human Ovarian Cancer via Inducing Apoptosis, Cell Cycle Arrest Through β-Catenin Pathway.
Jiang L; Hou R
Onco Targets Ther; 2020; 13():3631-3639. PubMed ID: 32431514
[TBL] [Abstract][Full Text] [Related]
15. Human epithelial-type ovarian tumour marker beta-2-microglobulin is regulated by the TGF-β signaling pathway.
Sun W; Gui L; Zuo X; Zhang L; Zhou D; Duan X; Ren W; Xu G
J Transl Med; 2016 Mar; 14():75. PubMed ID: 26983758
[TBL] [Abstract][Full Text] [Related]
16. miR-1-3p Inhibits Osteosarcoma Cell Proliferation and Cell Cycle Progression While Promoting Cell Apoptosis by Targeting CDK14 to Inactivate Wnt/Beta-Catenin Signaling.
Zhang G; Guan Q; Zhao Y; Wang S; Li H
Mol Biotechnol; 2023 Jul; ():. PubMed ID: 37420040
[TBL] [Abstract][Full Text] [Related]
17. CDK14/β-catenin/TCF4/miR-26b positive feedback regulation modulating pancreatic cancer cell phenotypes in vitro and tumor growth in mice model in vivo.
Sun Y; Wang P; Zhang Q; Wu H
J Gene Med; 2022 Feb; 24(2):e3343. PubMed ID: 33871149
[TBL] [Abstract][Full Text] [Related]
18. Cystatin B is a progression marker of human epithelial ovarian tumors mediated by the TGF-β signaling pathway.
Wang X; Gui L; Zhang Y; Zhang J; Shi J; Xu G
Int J Oncol; 2014 Apr; 44(4):1099-106. PubMed ID: 24452274
[TBL] [Abstract][Full Text] [Related]
19. Gomisin A enhances the antitumor effect of paclitaxel by suppressing oxidative stress in ovarian cancer.
Wang T; Liu J; Huang X; Zhang C; Shangguan M; Chen J; Wu S; Chen M; Yang Z; Zhao S
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36169181
[TBL] [Abstract][Full Text] [Related]
20. KLF8 is activated by TGF-β1 via Smad2 and contributes to ovarian cancer progression.
Cherukunnath A; Davargaon RS; Ashraf R; Kamdar U; Srivastava AK; Tripathi PP; Chatterjee N; Kumar S
J Cell Biochem; 2022 May; 123(5):921-934. PubMed ID: 35293014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
